Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Anti-Cancer Drugs
|
July 1, 1997
Individualizing chemotherapy for solid tumors--is there any alternative?
I A Cree, C M Kurbacher
Anti-Cancer Drugs
|
November 15, 2001
The role of chemotherapy in invasive cancer of the cervix uteri: current standards and future prospects
D T Rein, C M Kurbacher
Anti-Cancer Drugs
|
September 7, 1999
ATP-based tumor chemosensitivity testing: assisting new agent development
I A Cree, C M Kurbacher
Anticancer Research
|
August 15, 1998
Chemoprotection in anticancer therapy: the emerging role of amifostine (WR-2721)
C M Kurbacher, P K Mallmann
Anti-Cancer Drugs
|
December 29, 2000
Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
M Schwonzen, C M Kurbacher, P Mallmann
Gynecologic and Obstetric Investigation
|
June 16, 2001
Detection of aberrations of chromosome 17 and p53 gene expression and their correlation to histologic grading and prognosis in primary invasive squamous cell carcinoma of the cervix
P Boabang, C M Kurbacher, A Waida, et al.
Cancer
|
November 1, 1996
Tumor chemosensitivity and chemoresistance assays
I A Cree, R D Petty, C M Kurbacher, et al.
Zentralblatt Fur Gynakologie
|
January 1, 1996
[Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay]
C M Kurbacher, U Brenne, J A Kurbacher, et al.
Anticancer Research
|
May 1, 2001
Ex vivo assays to evaluate the role of protein kinase C in tumor cells of patients with breast cancer
T Schöndorf, M Becker, H Kolhagen, et al.
Geburtshilfe Und Frauenheilkunde
|
February 1, 1996
-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-
C M Kurbacher, P Mallmann, J A Kurbacher, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Anti-Cancer Drugs
|
July 1, 1997
Individualizing chemotherapy for solid tumors--is there any alternative?
I A Cree, C M Kurbacher
Anti-Cancer Drugs
|
November 15, 2001
The role of chemotherapy in invasive cancer of the cervix uteri: current standards and future prospects
D T Rein, C M Kurbacher
Anti-Cancer Drugs
|
September 7, 1999
ATP-based tumor chemosensitivity testing: assisting new agent development
I A Cree, C M Kurbacher
Anticancer Research
|
August 15, 1998
Chemoprotection in anticancer therapy: the emerging role of amifostine (WR-2721)
C M Kurbacher, P K Mallmann
Anti-Cancer Drugs
|
December 29, 2000
Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
M Schwonzen, C M Kurbacher, P Mallmann
Gynecologic and Obstetric Investigation
|
June 16, 2001
Detection of aberrations of chromosome 17 and p53 gene expression and their correlation to histologic grading and prognosis in primary invasive squamous cell carcinoma of the cervix
P Boabang, C M Kurbacher, A Waida, et al.
Cancer
|
November 1, 1996
Tumor chemosensitivity and chemoresistance assays
I A Cree, R D Petty, C M Kurbacher, et al.
Zentralblatt Fur Gynakologie
|
January 1, 1996
[Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay]
C M Kurbacher, U Brenne, J A Kurbacher, et al.
Anticancer Research
|
May 1, 2001
Ex vivo assays to evaluate the role of protein kinase C in tumor cells of patients with breast cancer
T Schöndorf, M Becker, H Kolhagen, et al.
Geburtshilfe Und Frauenheilkunde
|
February 1, 1996
-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-
C M Kurbacher, P Mallmann, J A Kurbacher, et al.
Page
of 4